Free Trial
NASDAQ:APYX

Apyx Medical (APYX) Stock Price, News & Analysis

Apyx Medical logo
$1.51 +0.06 (+3.82%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$1.46 -0.05 (-3.64%)
As of 02/21/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Apyx Medical Stock (NASDAQ:APYX)

Key Stats

Today's Range
$1.45
$1.51
50-Day Range
$1.36
$1.76
52-Week Range
$0.97
$2.30
Volume
6,061 shs
Average Volume
27,108 shs
Market Capitalization
$56.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Moderate Buy

Company Overview

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Apyx Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
29th Percentile Overall Score

APYX MarketRank™: 

Apyx Medical scored higher than 29% of companies evaluated by MarketBeat, and ranked 795th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Apyx Medical are expected to grow in the coming year, from ($0.68) to ($0.33) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Apyx Medical is -1.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Apyx Medical is -1.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Apyx Medical has a P/B Ratio of 1.94. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Apyx Medical's valuation and earnings.
  • Percentage of Shares Shorted

    0.47% of the float of Apyx Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Apyx Medical has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Apyx Medical has recently increased by 0.40%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Apyx Medical does not currently pay a dividend.

  • Dividend Growth

    Apyx Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.47% of the float of Apyx Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Apyx Medical has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Apyx Medical has recently increased by 0.40%, indicating that investor sentiment is decreasing.
    • Insider Buying vs. Insider Selling

      In the past three months, Apyx Medical insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      16.80% of the stock of Apyx Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      55.33% of the stock of Apyx Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

    • Read more about Apyx Medical's insider trading history.
    Receive APYX Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter.

    APYX Stock News Headlines

    Buy this AI Stock Before Elon’s Announcement
    With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dust. This isn't just a prediction; it's a calculated shift backed by political support, policy changes, and Musk's proven track record. I've identified a company that is quietly enabling xAI's rapid growth.
    NeoGenomics (NEO) Gets a Buy from Craig-Hallum
    Craig-Hallum Remains a Buy on Apyx Medical (APYX)
    Apyx Medical submits 510k premarket notification to FDA for AYON BCS
    See More Headlines

    APYX Stock Analysis - Frequently Asked Questions

    Apyx Medical's stock was trading at $1.58 at the start of the year. Since then, APYX stock has decreased by 4.4% and is now trading at $1.51.
    View the best growth stocks for 2025 here
    .

    Apyx Medical Co. (NASDAQ:APYX) released its earnings results on Friday, November, 8th. The company reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.01. The business earned $11.49 million during the quarter, compared to analysts' expectations of $11.66 million. Apyx Medical had a negative trailing twelve-month return on equity of 137.98% and a negative net margin of 58.59%.

    Top institutional shareholders of Apyx Medical include Nantahala Capital Management LLC (8.42%), Archon Capital Management LLC (8.34%), Royce & Associates LP (6.95%) and Taylor Frigon Capital Management LLC (1.45%). Insiders that own company stock include Charles D Goodwin II and Todd Hornsby.
    View institutional ownership trends
    .

    Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Apyx Medical investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), AUO (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

    Company Calendar

    Last Earnings
    11/08/2024
    Today
    2/21/2025
    Next Earnings (Estimated)
    5/07/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Sector
    Medical
    Industry
    Surgical & medical instruments
    Sub-Industry
    Medical Equipment
    Current Symbol
    NASDAQ:APYX
    Employees
    270
    Year Founded
    N/A

    Profitability

    Net Income
    $-18,710,000.00
    Pretax Margin
    -58.25%

    Debt

    Sales & Book Value

    Annual Sales
    $48.54 million
    Book Value
    $0.78 per share

    Miscellaneous

    Free Float
    31,320,000
    Market Cap
    $56.84 million
    Optionable
    Optionable
    Beta
    1.25
    (Almost)  Everything You Need To Know About The EV Market Cover

    Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

    Get This Free Report

    This page (NASDAQ:APYX) was last updated on 2/22/2025 by MarketBeat.com Staff
    From Our Partners